PMID: 9533730Apr 9, 1998Paper

The molecular mechanisms of tetracycline resistance in the pneumococcus

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
C A Widdowson, Keith P Klugman

Abstract

Tetracycline resistance in the pneumococcus is a result of the acquisition of one of two resistance determinants, tet(M) or tet(O). These genes encode ribosomal protection proteins that have homology to the elongation factors G and Tu. Tet(M) and Tet(O) both have GTPase activity that appears to be important in the displacement of tetracycline from the ribosome. Modification of tRNA may also be important for tetracycline resistance. Transcription of tet(M) is thought to be regulated by transcriptional attenuation. Transcription of tet(O) is constitutive, however, upstream of the gene are sequences that also appear to be involved in transcriptional attenuation. tet(M) is transferred on the conjugative transposons, Tn1545 and Tn5151. It is not yet known whether tet(O) is transported on transposons or plasmids, or whether it is chromosomally integrated, in pneumococci.

References

Oct 1, 1992·Clinical Microbiology Reviews·B S SpeerA A Salyers
Apr 1, 1992·Antimicrobial Agents and Chemotherapy·S B Levy
Mar 1, 1992·The Journal of Antimicrobial Chemotherapy·I ChopraM Hinton
Feb 1, 1992·Antimicrobial Agents and Chemotherapy·C Poyart-SalmeronP Courvalin
Oct 1, 1991·Antimicrobial Agents and Chemotherapy·Y Wang, D E Taylor
Oct 25, 1990·Nucleic Acids Research·V Burdett
Jan 1, 1990·Antimicrobial Agents and Chemotherapy·E K ManavathuD E Taylor
Jan 1, 1990·Journal of Bacteriology·P S Lovett
Jul 1, 1989·The Journal of Antimicrobial Chemotherapy·S B Levy
Sep 1, 1989·The Journal of Antimicrobial Chemotherapy·R C MoelleringD E Sentochnik
Sep 1, 1989·Antimicrobial Agents and Chemotherapy·M C Roberts
Aug 1, 1987·Molecular & General Genetics : MGG·F Caillaud, P Courvalin
Jul 1, 1988·Journal of Bacteriology·D B ClewellC Gawron-Burke
Jul 1, 1985·Antimicrobial Agents and Chemotherapy·M C RobertsG E Kenny
Jun 1, 1986·Journal of Bacteriology·M N VijayakumarW R Guild
Nov 1, 1986·Molecular & General Genetics : MGG·P Courvalin, C Carlier
Jan 1, 1987·Plasmid·F CaillaudP Courvalin
Feb 1, 1987·Molecular & General Genetics : MGG·P Courvalin, C Carlier
Dec 1, 1988·Antimicrobial Agents and Chemotherapy·R ZilhaoP Courvalin
Oct 1, 1987·Antimicrobial Agents and Chemotherapy·L M McMurryS B Levy
Feb 1, 1986·Antimicrobial Agents and Chemotherapy·M C Roberts, G E Kenny
Jan 1, 1987·Nucleic Acids Research·M SprinzlT Vorderwülbecke
Dec 15, 1986·European Journal of Biochemistry·U Geigenmüller, K H Nierhaus
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·M C RobertsG E Kenny
Mar 1, 1982·Journal of Bacteriology·V BurdettS Rajagopalan
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·L McMurryS B Levy
Jul 1, 1981·The Journal of Antimicrobial Chemotherapy·I ChopraD C Speller
Jun 1, 1995·Trends in Microbiology·D B ClewellD D Jaworski
Oct 1, 1994·Trends in Microbiology·M C Roberts
Mar 1, 1994·The Journal of Antimicrobial Chemotherapy·M C RobertsM E Mulligan

❮ Previous
Next ❯

Citations

Sep 2, 1999·Infectious Disease Clinics of North America·K P Klugman, S A Madhi
Nov 24, 1999·International Journal of Antimicrobial Agents·L LatiniR Ronchetti
Jan 26, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph P Lynch III, Fernando J Martinez
Jan 11, 2007·Antimicrobial Agents and Chemotherapy·Radosław IzdebskiWaleria Hryniewicz
Oct 5, 2001·Clinical Microbiology Reviews·A C FluitF J Schmitz
Oct 24, 2000·Tropical Medicine & International Health : TM & IH·M LarssonT Falkenberg
Oct 9, 2003·Journal of Medical Microbiology·Ralf René ReinertRudolf Lütticken

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.